Share Email Print

Proceedings Paper

Sidefiring laser-fiber technology for minimally invasive transurethral treatment of benign prostatic hyperplasia
Author(s): Millard M. Judy; James Lester Matthews; W. W. Gardetto; R. V. Everett; H. A. Lahon
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

We have designed and are fabricating the SideFireR laser optical fiber device incorporating a 99.95+% purity gold tip with a mirror which laterally reflects the beam at a 105 degree(s) angle to the optical fiber axis while closely maintaining the beam profile. The monolithic gold construction of the mirrored tip underlies the optical and thermal stability and the bicompatibility of the device during lasing in aqueous environments using up to 80 W of Nd:YAG 1.064 micrometers radiation. Current studies are being conducted to evaluate the use of this device in laser coagulation of the prostate as an alternative treatment to transurethral resection in treatment of benign prostatic hypertrophy.

Paper Details

Date Published: 7 July 1993
PDF: 5 pages
Proc. SPIE 1892, Medical Lasers and Systems II, (7 July 1993); doi: 10.1117/12.147488
Show Author Affiliations
Millard M. Judy, Baylor Research Institute and MicroBioMed (United States)
James Lester Matthews, Baylor Research Institute and MicroBioMed (United States)
W. W. Gardetto, MicroBioMed (United States)
R. V. Everett, Myriadlase, Inc. (United States)
H. A. Lahon, Myriadlase, Inc. (United States)

Published in SPIE Proceedings Vol. 1892:
Medical Lasers and Systems II
David M. Harris; Carl Murray Penney; Abraham Katzir, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?